Regarding the evaluation of ALK and ROS1 gene rearrangements, IHC/ICC was employed in the vast majority of cases (n = 74, 89.2%), whereas RNA-based NGS analysis was adopted in only n = 9 (10.8%) instances. This evidence concerns the gene ROS1 and intrahepatic cholangiocarcinoma.